TGIF

TGIF

Listen the way things have been going in this wacky world of ours we couldn’t be happier that Friday has finally arrived and the weekend beckons. Yesterday the diabetes community was in a tether trying to figure out just what the heck is going on at Tandem (NASDAQ: TNDM). Rumors were swirling that there was a company out there that wanted to throw good money into a very bad situation and buy the company. Was it Roche, Abbott (NYSE: ABT), Novo Nordisk (NYSE: NVO), Lilly (NYSE: LLY) or perhaps Google or Apple . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.